- Home
- GEG vs PYXS Comparison
GEG vs PYXS Comparison
Compare GEG & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GEG | PYXS |
|---|---|---|
| Founded | 1994 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.9M | 71.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GEG | PYXS |
|---|---|---|
| Price | $2.00 | $1.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | 9.0K | ★ 1.2M |
| Earning Date | 02-04-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $22,616,000.00 | $2,820,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.77 | N/A |
| 52 Week Low | $1.76 | $0.83 |
| 52 Week High | $3.51 | $5.55 |
Technical Indicators
Market Signals| Indicator | GEG | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | 27.43 | 36.12 |
| Support Level | $1.92 | $1.38 |
| Resistance Level | $2.14 | $1.69 |
| Average True Range (ATR) | 0.12 | 0.13 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 25.96 | 10.69 |
Price Performance
Historical ComparisonAbout GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.